Cidara Therapeutics Inc (NASDAQ:CDTX)

2.01
Delayed Data
As of May 07
 -0.01 / -0.50%
Today’s Change
1.82
Today|||52-Week Range
4.45
+0.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization461.0K732.0K667.0K523.0K
 
 
 
 
 
 
Operating ExpensesGross Income-461.0K-732.0K-667.0K-523.0K
 
 
 
 
 
General Expenses31.9M47.7M55.1M62.8M
 
 
 
 
 
Research And Development23.5M35.7M42.8M49.1M
 
 
 
 
 
Total Operating Expenses32.3M48.4M55.7M63.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.3M-48.4M-55.7M-63.3M
 
 
 
 
 
Extraordinary Credit0.000.000.003.9M
 
 
Interest Expense On Debt0.0022.0K7.0K--
 
 
 
Other Expenses0.000.000.00-211.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.2M-48.2M-55.7M-59.0M
 
 
 
 
 
Net Income-32.2M-48.2M-55.7M-69.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.9M14.5M17.5M25.1M
 
 
 
 
 
Shares To Calculate EPS Diluted9.9M14.5M17.5M25.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.25-$3.32-$3.18-$2.76
 
 
 
 
 
EPS Diluted-$3.25-$3.32-$3.18-$2.76